So far, only few diagnostic markers are well recognized in invasive BC, including expression of the two nuclear receptors (NR), the estrogen receptor (ER) and progesterone receptor (PR), and overexpression of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast cancer.